| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016675 |
| Receipt No. | R000019261 |
| Official scientific title of the study | Morphological and Functional Change of Coronary Perivascular Adipose Tissue in Vasospastic Angina |
| Date of disclosure of the study information | 2015/03/09 |
| Last modified on | 2018/03/04 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Morphological and Functional Change of Coronary Perivascular Adipose Tissue in Vasospastic Angina | |
| Title of the study (Brief title) | ADIPO-VSA Trial | |
| Region |
|
|
| Condition | ||||
| Condition | Vasospastic angina | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The purpose of this study is to investigate the relationship between vasospastic angina and morphological and functional change of coronary perivascular adipose tissue. |
| Basic objectives2 | Others |
| Basic objectives -Others | Morphological change of coronary perivascular adipose tissue is assessed by volume measured by cardiac CT, functional change is assessed by FDG-uptake measured by 18F-FDG PET. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | (1)Coronary perivascular adipose tissue volume measured by cardiac CT.
|
| Key secondary outcomes | (2)FDG-uptake of coronary perivascular adipose tissue measured by 18F-FDG PET.
(3)FDG-uptake of vascular wall in which vasospasm occurs measured by 18F-FDG PET. (4)Vasa vasorum measured by OFDI (5)General blood examination deta, adiponectin, Rho-kinase activity (6)Metabolite measured by metabolome analysis (7)Exercise tolerance measured by cardiopulmonary exercise test (8)FDG-uptake of coronary perivascular adipose tissue measured by 18F-FDG PET at the time of follow-up. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who are suspected of vasospastic angina. | |||
| Key exclusion criteria | (1) Acute coronary syndrome
(2) EF is under 40%. (3) Severe renal failure. (4) Severe contrast media allergy (5) history of cardiac surgery (6) Severe asthma (7) Diabetes which needs insulin therapy |
|||
| Target sample size | 150 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Shimokawa |
| Organization | Tohoku University Hospital |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan |
| TEL | +81-22-717-7153 |
| shimo@cardio.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Yasuharu Matsumoto |
| Organization | Tohoku University Hospital |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan |
| TEL | +81-22-717-7153 |
| Homepage URL | |
| matsumoto@cardio.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Mochida Memorial Foundation for Medical and Pharmaceutical Research |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | Banyu Life Science Foundation International |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東北大学病院(宮城県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | Patient's information is blinded to a person analyzing data of CT and PET. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019261 |